Sacheerome
H1 FY27 steady: income +9.84% to ₹85.92 Cr, PAT +12.38% to ₹16.79 Cr, EBITDA margin 27.57%. YEIDA plant in trial, commercial output awaits certificates. Capex and utilisation answers evasive.
ALFA Concalls
Every earnings call, live and summarised
Earnings calls
Every Sacheerome earnings call we streamed: the live audio and our summary of what management said.
H1 FY27 steady: income +9.84% to ₹85.92 Cr, PAT +12.38% to ₹16.79 Cr, EBITDA margin 27.57%. YEIDA plant in trial, commercial output awaits certificates. Capex and utilisation answers evasive.
H1 FY27 steady: income +9.84% to ₹85.92 Cr, PAT +12.38% to ₹16.79 Cr, EBITDA margin 27.57%. YEIDA plant in trial, commercial output awaits certificates. Capex and utilisation answers evasive.
Reaffirmed ₹300 Cr FY29 revenue projection. No growth % or utilisation timeline guided.
Sacheerome Limited reported record FY26 results with Revenue of ₹152.39cr and 26.02% EBITDA margin. Strategy focuses on a 4x capacity expansion via the new YEIDA facility.
Sacheerome Limited delivered robust H2 FY26 performance with Revenue at ₹7,582 Lakhs and PAT at ₹1,350 Lakhs, driven by its dual fragrance and flavour segments and B2B FMCG focus.
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.